Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis
Clinical trial NCT06526104 · RECRUITING
Trial details
- NCT number
- NCT06526104
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-02
- Primary completion
- 2027-10-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.